Commission Decision

of 15 June 2000

recognising in principle the completeness of the dossier submitted for detailed examination with a view to the possible inclusion of IKF 916 (cyazofamid) in Annex I to Council Directive 91/414/EEC concerning the placing of plant protection products on the market

(notified under document number C(2000) 1547)

(2000/412/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant-protection products on the market(1), as last amended by Commission Directive 1999/80/EC(2), and in particular Article 6(3) thereof,

Whereas:

(1) Directive 91/414/EEC (hereinafter referred to as "the Directive") provides for the compilation of a Community list of active substance authorised for use in plant protection products.

(2) Ishira Sangyo Kaisha Ltd submitted a dossier on the active substance IKF 916 (cyazofamid) to the French authorities on 16 December 1999.

(3) The said authorities informed the Commission of the results of an initial examination of the dossier to ensure that it provides all the information laid down in Annex II and, for at least one plant protection product containing the active substance concerned, in Annex III to the Directive. Subsequently, in accordance with Article 6(2), the applicant submitted the dossier to the Commission and other Member States.

(4) The dossier on IKF 916 (cyazofamid) was referred to the Standing Committee on Plant Health on 20 March 2000.

(5) Article 6(3) of the Directive requires official confirmation at Community level that each dossier fulfils the requirements on information laid down in Annex II and, for at least one plant protection product containing the active substance concerned, in Annex III to the Directive.

(6) Such confirmation is necessary to permit a detailed examination of the dossier and to allow Member States to grant provisional authorisation for plant protection products containing the active substance concerned while complying with the conditions laid down in Article 8(1) of the Directive and, in particular, the condition relating to the detailed assessment of the active substance and the plant protection product in the light of the requirements laid down by the Directive.

(7) Such decision does not prejudice that further data or information may be requested from the applicant in order to clarify certain points in the dossier. The request by the rapporteur Member State for the submission of further data necessary to clarify the dossier shall not affect the time limit for the submission of the report referred to under recital 9.

(8) The Member States and the Commission agree that France will carry out a detailed examination of the dossier on IKF 916 (cyazofamid).

(9) France will report the conclusions of their examinations accompanied by any recommendations on the inclusion or non-inclusion and any conditions relating thereto as soon as possible and at the latest within a period of one year from the date of publication of this Decision.

(10) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plant Health,

HAS ADOPTED THIS DECISION:

Article 1

The following dossier satisfies in principle the information requirements laid down in Annex II and, for at least one plant protection product containing the active substance concerned, in Annex III to the Directive, taking account of the intended uses:

the dossier submitted by Ishira Sangyo Kaisha Ltd to the Commission and the Member States with a view to the inclusion of IKF 916 (cyazofamid) as an active substance in Annex I to Directive 91/414/EEC and referred to the Standing Committee on Plant Health on 20 March 2000.

Article 2

This Decision is addressed to the Member States.

Done at Brussels, 15 June 2000.

For the Commission

David Byrne

Member of the Commission

(1) OJ L 230, 19.8.1991, p. 1.

(2) OJ L 210, 10.8.1999, p. 13.